HomeAI · summaries
Storia in 8 fonti
Let the orexin market begin: Takeda snags FDA approval for narcolepsy type 1 drug
Takeda's Orzeyful wins FDA approval as the first full-symptom narcolepsy type 1 drug, kicking off an orexin agonist race with Lilly and Alkermes close behind.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
caixinglobal.com
China Beats U.S. in Approving Takeda’s Breakthrough Narcolepsy Drug
The milestone marks the first time a first-in-class drug using global clinical data has been filed and approved in China ahead of the rest of the world
- ·
statnews.com
Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.
